Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
6,610
+176
+3% +$60.2K 0.88% 26
2026
Q1
$2.26M Sell
6,434
-589
-8% -$210K 0.94% 24
2025
Q4
$2.3M Buy
7,023
+24
+0.3% +$7.61K 0.91% 24
2025
Q3
$1.97M Sell
6,999
-27
-0.4% -$7.83K 0.84% 25
2025
Q2
$1.96M Sell
7,026
-121
-2% -$34.3K 0.93% 24
2025
Q1
$2.23M Buy
7,147
+71
+1% +$21K 1.23% 21
2024
Q4
$1.84M Sell
7,076
-30
-0.4% -$8.9K 1.04% 23
2024
Q3
$2.29M Sell
7,106
-60
-0.8% -$19.6K 1.29% 22
2024
Q2
$2.24M Sell
7,166
-6
-0.1% -$1.76K 1.7% 17
2024
Q1
$2.04M Buy
7,172
+4
+0.1% +$1.17K 1.63% 16
2023
Q4
$2.06M Hold
7,168
1.89% 15
2023
Q3
$1.93M Sell
7,168
-1
-0% -$250 2.07% 15
2023
Q2
$1.59M Buy
7,169
+3,438
+92% +$798K 1.69% 17
2023
Q1
$902K Sell
3,731
-6
-0.2% -$1.47K 1.08% 20
2022
Q4
$981K Buy
+3,737
New +$1M 1.26% 20

Other funds holding AMGN

FMB Wealth Management's AMGN Position: Q2 2026 in Review

FMB Wealth Management increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $60.2K and bringing the position to 6,610 shares worth $2.39M. The position accounts for 0.88% of the portfolio, ranked #26.

FMB Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • FMB Wealth Management held 6,610 shares of Amgen worth $2.39M as of Q2 2026.
  • FMB Wealth Management bought 176 Amgen shares in Q2 2026, an estimated $60.2K.
  • Amgen made up 0.88% of FMB Wealth Management's portfolio in Q2 2026, its #26 holding.
  • FMB Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on FMB Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.